NCT01900093View on ClinicalTrials.gov

Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses

NAUnknownINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Multiple Sclerosis

Interventions

DRUG

Acthar Gel

80 units of subcutaneous Acthar Gel therapy daily

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

Aaron Miller

OTHER